HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takeharu Kanazawa Selected Research

Vocal Cord Paralysis

6/2022Effect of intracordal injection under local anesthesia on vital signs in high-risk patients.
9/2017Injection of basic fibroblast growth factor for unilateral vocal cord paralysis.
2/2014Phonological outcome of laryngeal framework surgery by different anesthesia protocols: a single-surgeon experience.
5/2012Arytenoid adduction combined with medialization laryngoplasty under general anesthesia using a laryngeal mask airway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takeharu Kanazawa Research Topics

Disease

27Squamous Cell Carcinoma of Head and Neck
01/2020 - 07/2007
22Neoplasms (Cancer)
09/2020 - 09/2004
17Head and Neck Neoplasms (Head and Neck Cancer)
11/2018 - 09/2004
8Carcinogenesis
01/2020 - 01/2012
4Vocal Cord Paralysis
06/2022 - 05/2012
3Paralysis (Palsy)
06/2022 - 02/2010
3Cicatrix (Scar)
11/2021 - 10/2015
3Oropharyngeal Neoplasms
09/2020 - 01/2015
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2019 - 04/2009
2Edema (Dropsy)
11/2021 - 01/2021
2Carcinoma (Carcinomatosis)
06/2018 - 06/2013
2Facial Paralysis (Facial Palsy)
06/2018 - 02/2010
2Small Cell Carcinoma
05/2016 - 12/2012
2Otitis Media with Effusion
02/2010 - 01/2010
2Otitis Media
02/2010 - 10/2008
1Thoracic Aortic Aneurysm
06/2022
1Thoracic Aorta Dissection
06/2022
1Esophageal Diseases
06/2022
1Aortic Diseases
06/2022
1Thyroid Diseases (Thyroid Disease)
06/2022
1Polyps
11/2021
1Dysphonia (Spastic Dysphonia)
01/2021
1Atrophy
12/2020
1Hoarseness
08/2020
1Autoimmune Diseases (Autoimmune Disease)
08/2020
1Genomic Instability
01/2020
1Hematoma
01/2015
1Disease Progression
03/2014
1Lymphatic Metastasis
03/2014
1Asthenia
02/2014
1Epithelioid Hemangioendothelioma
10/2013
1Cholesteatoma
07/2012
1Carcinoid Tumor (Carcinoid)
02/2011
1Mixed Conductive-Sensorineural Hearing Loss
02/2010
1Vasculitis (Vasculitides)
02/2010
1Bacterial Infections (Bacterial Infection)
01/2010
1Inflammation (Inflammations)
01/2010
1Neoplasm Metastasis (Metastasis)
07/2007

Drug/Important Bio-Agent (IBA)

14Biomarkers (Surrogate Marker)IBA
09/2020 - 01/2012
11GalaninIBA
06/2018 - 04/2009
10Galanin Receptors (Galanin Receptor)IBA
01/2019 - 04/2009
6Proteins (Proteins, Gene)FDA Link
05/2018 - 01/2010
4Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
06/2022 - 10/2015
3G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
09/2020 - 08/2015
3Messenger RNA (mRNA)IBA
07/2019 - 03/2014
3Type 1 Galanin ReceptorIBA
01/2017 - 12/2008
3Cyclin D1IBA
08/2015 - 12/2008
3Tachykinin Receptors (Tachykinin Receptor)IBA
08/2015 - 05/2013
3Type 2 Galanin ReceptorIBA
09/2014 - 03/2010
2Hormones (Hormone)IBA
01/2021 - 06/2018
2Circulating Tumor DNAIBA
09/2020 - 01/2020
2ElementsIBA
01/2020 - 05/2016
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 11/2018
2Neuropeptide Receptors (Neuropeptide Receptor)IBA
01/2020 - 09/2017
2Biological ProductsIBA
06/2018 - 10/2013
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
07/2017 - 10/2013
2H-cadherin (T-cadherin)IBA
05/2016 - 01/2012
2Cadherins (E-Cadherin)IBA
05/2016 - 05/2013
2alpha2 Subunit Collagen Type IIBA
05/2016 - 01/2012
2somatostatin receptor type 1IBA
08/2015 - 01/2015
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015 - 10/2013
2CollagenIBA
03/2014 - 01/2012
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
06/2022
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
11/2021
1SteroidsIBA
11/2021
1Therapeutic UsesIBA
01/2021
1GlucocorticoidsIBA
08/2020
1AutoantibodiesIBA
08/2020
1Retroelements (Retrotransposon)IBA
01/2020
1NucleotidesIBA
01/2020
1human ERBB2 proteinIBA
06/2018
1NeuropeptidesIBA
01/2018
1Indicators and Reagents (Reagents)IBA
07/2017
1hydroxide ionIBA
01/2015
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2015
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2015
1cytidylyl-3'-5'-guanosineIBA
01/2014
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2014
1Fluorouracil (Carac)FDA LinkGeneric
06/2013
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
02/2010
1EnzymesIBA
01/2010
1Immunoglobulin E (IgE)IBA
01/2010
1Annexin A5IBA
04/2009
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
07/2007
1Glycoproteins (Glycoprotein)IBA
07/2007
1Interleukin-6 (Interleukin 6)IBA
07/2007
1Topoisomerase InhibitorsIBA
09/2004

Therapy/Procedure

8Therapeutics
01/2021 - 06/2008
3Injections
12/2020 - 10/2015
2General Anesthesia
02/2014 - 05/2012
1Local Anesthesia
06/2022
1Drug Therapy (Chemotherapy)
11/2018
1Laryngectomy
05/2016
1Neck Dissection (Radical Neck Dissection)
05/2016
1Anesthesia
02/2014
1Intra-Arterial Infusions
06/2013
1Middle Ear Ventilation (Tympanostomy)
07/2012
1Laryngoplasty
05/2012
1Molecular Targeted Therapy
02/2011
1Tympanoplasty
10/2008